Beam Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference

CAMBRIDGE, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a panel titled, So Let it Be (Re)Written - Updates in Gene Modulation during the 2022 Wedbush PacGrow Virtual Healthcare Conference on Tuesday, August 9, 2022 at 9:45 a.m.